Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

Related Articles by Review for PubMed (Select 20368123)

1.

In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project.

Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, Reif DM, Rotroff DM, Shah I, Richard AM, Dix DJ.

Environ Health Perspect. 2010 Apr;118(4):485-92. doi: 10.1289/ehp.0901392.

2.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
3.

Chemical testing strategies for predicting health hazards to children.

Lamb JC, Brown SM.

Reprod Toxicol. 2000 Mar-Apr;14(2):83-94. Review.

PMID:
10825671
4.

The toxicity data landscape for environmental chemicals.

Judson R, Richard A, Dix DJ, Houck K, Martin M, Kavlock R, Dellarco V, Henry T, Holderman T, Sayre P, Tan S, Carpenter T, Smith E.

Environ Health Perspect. 2009 May;117(5):685-95. doi: 10.1289/ehp.0800168. Epub 2008 Dec 22. Review.

5.

The future of toxicity testing.

Andersen ME, Al-Zoughool M, Croteau M, Westphal M, Krewski D.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):163-96. doi: 10.1080/10937404.2010.483933. Review.

PMID:
20574896
6.

Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.

Pickford DB.

Crit Rev Toxicol. 2010 Nov;40(10):845-92. doi: 10.3109/10408444.2010.494250. Review.

PMID:
20684730
7.

In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme.

Judson R, Houck K, Martin M, Knudsen T, Thomas RS, Sipes N, Shah I, Wambaugh J, Crofton K.

Basic Clin Pharmacol Toxicol. 2014 Jul;115(1):69-76. doi: 10.1111/bcpt.12239. Epub 2014 Apr 22. Review.

PMID:
24684691
8.

Chemical Safety for Sustainability (CSS): human in vivo biomonitoring data for complementing results from in vitro toxicology--a commentary.

Pleil JD, Williams MA, Sobus JR.

Toxicol Lett. 2012 Dec 17;215(3):201-7. doi: 10.1016/j.toxlet.2012.10.011. Epub 2012 Oct 30. Review.

PMID:
23116968
10.

Zebrafish: as an integrative model for twenty-first century toxicity testing.

Sipes NS, Padilla S, Knudsen TB.

Birth Defects Res C Embryo Today. 2011 Sep;93(3):256-67. doi: 10.1002/bdrc.20214. Review.

PMID:
21932434
11.

Toxicity testing in the 21st century: bringing the vision to life.

Andersen ME, Krewski D.

Toxicol Sci. 2009 Feb;107(2):324-30. doi: 10.1093/toxsci/kfn255. Epub 2008 Dec 12. Review.

12.

In vitro models in endocrine disruptor screening.

Charles GD.

ILAR J. 2004;45(4):494-501. Review.

13.

Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.

Borgert CJ, Mihaich EM, Quill TF, Marty MS, Levine SL, Becker RA.

Regul Toxicol Pharmacol. 2011 Apr;59(3):397-411. doi: 10.1016/j.yrtph.2011.01.003. Epub 2011 Jan 18. Review.

PMID:
21251942
14.

Uncertainties for endocrine disrupters: our view on progress.

Daston GP, Cook JC, Kavlock RJ.

Toxicol Sci. 2003 Aug;74(2):245-52. Epub 2003 May 2. Review.

15.

Endocrine disrupters--testing strategies to assess human hazard.

Baker VA.

Toxicol In Vitro. 2001 Aug-Oct;15(4-5):413-9. Review.

PMID:
11566572
16.

Predictive models and computational toxicology.

Knudsen T, Martin M, Chandler K, Kleinstreuer N, Judson R, Sipes N.

Methods Mol Biol. 2013;947:343-74. doi: 10.1007/978-1-62703-131-8_26. Review.

PMID:
23138916
17.

The causes and prevention of cancer: the role of environment.

Ames BN, Gold LS.

Biotherapy. 1998;11(2-3):205-20. Review.

PMID:
9677052
18.

Current and future needs for developmental toxicity testing.

Makris SL, Kim JH, Ellis A, Faber W, Harrouk W, Lewis JM, Paule MG, Seed J, Tassinari M, Tyl R.

Birth Defects Res B Dev Reprod Toxicol. 2011 Oct;92(5):384-94. doi: 10.1002/bdrb.20335. Epub 2011 Sep 15. Review.

PMID:
21922641
19.
20.

Use of the laboratory rat as a model in endocrine disruptor screening and testing.

Gray LE Jr, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PM.

ILAR J. 2004;45(4):425-37. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk